Commensal microbiota regulate aldosterone

Area of Science:

• Microbiology
• Endocrinology
• Cardiovascular Physiology

Background:

• The gut microbiome plays a crucial role in host physiology, including cardiovascular health.
• The specific impact of the gut microbiome on aldosterone regulation remains largely unknown.
• Aldosterone is a key hormone in blood pressure regulation and cardiovascular disease.

Purpose of the Study:

• To investigate whether gut microbiota regulate host aldosterone levels.
• To explore the relationship between gut microbiota and aldosterone in the context of blood pressure regulation.

Main Methods:

• Enzyme-linked immunosorbent assays (ELISAs) were used to measure plasma aldosterone and plasma renin activity (PRA).
• Studies were conducted in female and male mice with intact, suppressed (antibiotic treatment), or absent (germ-free) gut microbiota.
• Urinary aldosterone levels were also examined.

Main Results:

• Suppression of gut microbiota via antibiotics led to increased plasma and urinary aldosterone in both sexes.
• Germ-free conditions (absent microbiota) also resulted in significantly increased plasma aldosterone compared to conventional mice.
• Increased plasma renin activity (PRA) was observed only in male mice when gut microbiota were suppressed, not in germ-free conditions.

Conclusions:

• Gut microbiota significantly influence aldosterone levels, suggesting a novel mechanism for blood pressure regulation.
• Modulating the gut microbiome may offer new therapeutic strategies for hypertension and primary aldosteronism.
• Targeting the gut microbiome could provide a pathway for developing microbiota-based interventions to manage blood pressure.